TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Incorporating More Physical Activity and Calcium in Teens (IMPACT): A School-Based Osteoporosis Prevention Program for Adolescent Girls
Brief Summary: The Incorporating More Physical Activity and Calcium in Teens (IMPACT) study was a behaviorally-based middle school nutrition and physical activity program for the prevention of osteoporosis. The goal of IMPACT was to increase calcium intake and physical activity to help build bone mass in girls.


Options:
A: Arm Label: New Moves Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: New Moves | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: New Moves; Assigned to Arm(s): New Moves Intervention Group
B: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Educational strategy; Type: EXPERIMENTAL; Interventions: Behavioral: Educational strategy | Arm Label: Screening strategy; Type: EXPERIMENTAL; Interventions: Behavioral: Screening strategy | Arm Label: Environmental strategy; Type: EXPERIMENTAL; Interventions: Other: Environmental strategy | Arm Label: Educational and Screening strategies; Type: EXPERIMENTAL; Interventions: Behavioral: Educational strategy, Behavioral: Screening strategy | Arm Label: Screening and Environmental strategies; Type: EXPERIMENTAL; Interventions: Behavioral: Screening strategy, Other: Environmental strategy | Arm Label: Educational and Environmental strategies; Type: EXPERIMENTAL; Interventions: Behavioral: Educational strategy, Other: Environmental strategy | Arm Label: the three strategies; Type: EXPERIMENTAL; Interventions: Behavioral: Educational strategy, Behavioral: Screening strategy, Other: Environmental strategy | Intervention Type: BEHAVIORAL; Name: Educational strategy; Assigned to Arm(s): Educational and Environmental strategies, Educational and Screening strategies, Educational strategy, the three strategies | Intervention Type: BEHAVIORAL; Name: Screening strategy; Assigned to Arm(s): Educational and Screening strategies, Screening and Environmental strategies, Screening strategy, the three strategies | Intervention Type: OTHER; Name: Environmental strategy; Assigned to Arm(s): Educational and Environmental strategies, Environmental strategy, Screening and Environmental strategies, the three strategies
C: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Intervention group
D: Intervention Type: BEHAVIORAL; Name: Incorporating More Physical Activity and Calcium in Teens (IMPACT) Program; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
Brief Summary: The purpose of the study is to assess the efficacy, safety and tolerability of NGX 4010 applied for 60 minutes for the treatment of PHN.


Options:
A: Arm Label: NGX-4010, 60 minutes; Type: EXPERIMENTAL; Interventions: Drug: NGX-4010, 8% capsaicin patch | Arm Label: NGX-4010, 30 minutes; Type: EXPERIMENTAL; Interventions: Drug: NGX-4010, 8% capsaicin patch | Arm Label: 0.04% conc. capsaicin patch, 60 min.; Type: OTHER; Interventions: Drug: 0.04% capsaicin patch | Arm Label: 0.04% conc. capsaicin patch, 30 min.; Type: OTHER; Interventions: Drug: 0.04% capsaicin patch | Intervention Type: DRUG; Name: NGX-4010, 8% capsaicin patch; Assigned to Arm(s): NGX-4010, 60 minutes | Intervention Type: DRUG; Name: 0.04% capsaicin patch; Assigned to Arm(s): 0.04% conc. capsaicin patch, 60 min. | Intervention Type: DRUG; Name: NGX-4010, 8% capsaicin patch; Assigned to Arm(s): NGX-4010, 30 minutes | Intervention Type: DRUG; Name: 0.04% capsaicin patch; Assigned to Arm(s): 0.04% conc. capsaicin patch, 30 min.
B: Intervention Type: DRUG; Name: Capsaicin Dermal Patch; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: Capsaicin Dermal Patch; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: NGX-4010; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Investigational Vertebroplasty Efficacy and Safety Trial (INVEST)
Brief Summary: Vertebroplasty is a procedure used to stabilize broken vertebrae, the bones that form the spine. This study will evaluate the effectiveness of vertebroplasty for the treatment of fractures due to osteoporosis.


Options:
A: Arm Label: vertebroplasty; Type: ACTIVE_COMPARATOR; Interventions: Procedure: percutaneous injection of cement into the vertebral body | Arm Label: Medical Treatment; Type: ACTIVE_COMPARATOR; Interventions: Other: Medical treatment | Intervention Type: PROCEDURE; Name: percutaneous injection of cement into the vertebral body; Assigned to Arm(s): vertebroplasty | Intervention Type: OTHER; Name: Medical treatment; Assigned to Arm(s): Medical Treatment
B: Arm Label: Vertebroplasty; Type: EXPERIMENTAL; Interventions: Device: Percutaneous vertebroplasty | Arm Label: Control Group; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Sham vertebroplasty | Intervention Type: DEVICE; Name: Percutaneous vertebroplasty; Assigned to Arm(s): Vertebroplasty | Intervention Type: PROCEDURE; Name: Sham vertebroplasty; Assigned to Arm(s): Control Group
C: Arm Label: AVAMAX; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Vertebroplasty | Arm Label: Simulated injection procedure; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Vertebroplasty; Assigned to Arm(s): AVAMAX
D: Arm Label: vertebroplasty; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Kyphoplasty | Arm Label: kyphoplasty; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Kyphoplasty | Intervention Type: PROCEDURE; Name: Kyphoplasty; Assigned to Arm(s): kyphoplasty, vertebroplasty

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Investigational Vertebroplasty Efficacy and Safety Trial (INVEST)
Brief Summary: Vertebroplasty is a procedure used to stabilize broken vertebrae, the bones that form the spine. This study will evaluate the effectiveness of vertebroplasty for the treatment of fractures due to osteoporosis.


Options:
A: Arm Label: vertebroplasty; Type: EXPERIMENTAL; Interventions: Procedure: percutaneous vertebroplasty | Arm Label: sham procedure; Type: SHAM_COMPARATOR; Interventions: Procedure: sham procedure | Intervention Type: PROCEDURE; Name: percutaneous vertebroplasty; Assigned to Arm(s): vertebroplasty | Intervention Type: PROCEDURE; Name: sham procedure; Assigned to Arm(s): sham procedure
B: Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Vertebroplasty | Intervention Type: PROCEDURE; Name: Vertebroplasty; Assigned to Arm(s): 1
C: Arm Label: Vertebroplasty; Type: EXPERIMENTAL; Interventions: Device: Percutaneous vertebroplasty | Arm Label: Control Group; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Sham vertebroplasty | Intervention Type: DEVICE; Name: Percutaneous vertebroplasty; Assigned to Arm(s): Vertebroplasty | Intervention Type: PROCEDURE; Name: Sham vertebroplasty; Assigned to Arm(s): Control Group
D: Arm Label: AVAMAX; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Vertebroplasty | Arm Label: Simulated injection procedure; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Vertebroplasty; Assigned to Arm(s): AVAMAX

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: RCT of a Novel Oral Contraceptive Initiation Method
Brief Summary: Women who choose to take birth control pills are currently instructed to begin taking the pills at the end of a menstrual cycle. This creates a window of time between when the woman is given the pills and when she begins taking them. Some women fail to begin taking the pills, placing them at increased risk of pregnancy. This study will evaluate a new approach to beginning birth control pills. Women will take the first pill in the doctor's office rather than waiting until the next menstrual cycle.


Options:
A: Arm Label: Mobile phone-based intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone-based intervention | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mobile phone-based intervention; Assigned to Arm(s): Mobile phone-based intervention
B: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Text Messages; Type: EXPERIMENTAL; Interventions: Other: Daily Text Messages | Intervention Type: OTHER; Name: Daily Text Messages; Assigned to Arm(s): Text Messages
C: Intervention Type: BEHAVIORAL; Name: Quick start oral contraceptive initiation; Assigned to Arm(s): N/A
D: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: follow-up phone counseling | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: follow-up phone counseling; Assigned to Arm(s): Treatment

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: RCT of a Novel Oral Contraceptive Initiation Method
Brief Summary: Women who choose to take birth control pills are currently instructed to begin taking the pills at the end of a menstrual cycle. This creates a window of time between when the woman is given the pills and when she begins taking them. Some women fail to begin taking the pills, placing them at increased risk of pregnancy. This study will evaluate a new approach to beginning birth control pills. Women will take the first pill in the doctor's office rather than waiting until the next menstrual cycle.


Options:
A: Intervention Type: BEHAVIORAL; Name: Quick start oral contraceptive initiation; Assigned to Arm(s): N/A
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Oral contraceptives--ethinyl estradiol, levonorgestrel | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oral contraceptives--ethinyl estradiol, levonorgestrel | Intervention Type: DRUG; Name: Oral contraceptives--ethinyl estradiol, levonorgestrel; Assigned to Arm(s): A, B
C: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Text Messages; Type: EXPERIMENTAL; Interventions: Other: Daily Text Messages | Intervention Type: OTHER; Name: Daily Text Messages; Assigned to Arm(s): Text Messages
D: Arm Label: Flexible (extended) regimen no. 1 of EE20/DRSP (BAY86-5300); Type: EXPERIMENTAL; Interventions: Drug: EE20/DRSP (BAY86-5300) | Arm Label: Flexible (extended) regimen no. 2 of EE20/DRSP (BAY86-5300); Type: EXPERIMENTAL; Interventions: Drug: EE20/DRSP (BAY86-5300) | Arm Label: Conventional regimen of EE20/DRSP (YAZ, BAY86-5300); Type: ACTIVE_COMPARATOR; Interventions: Drug: EE20/DRSP (YAZ, BAY86-5300) | Intervention Type: DRUG; Name: EE20/DRSP (BAY86-5300); Assigned to Arm(s): Flexible (extended) regimen no. 1 of EE20/DRSP (BAY86-5300) | Intervention Type: DRUG; Name: EE20/DRSP (BAY86-5300); Assigned to Arm(s): Flexible (extended) regimen no. 2 of EE20/DRSP (BAY86-5300) | Intervention Type: DRUG; Name: EE20/DRSP (YAZ, BAY86-5300); Assigned to Arm(s): Conventional regimen of EE20/DRSP (YAZ, BAY86-5300)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: RCT of a Novel Oral Contraceptive Initiation Method
Brief Summary: Women who choose to take birth control pills are currently instructed to begin taking the pills at the end of a menstrual cycle. This creates a window of time between when the woman is given the pills and when she begins taking them. Some women fail to begin taking the pills, placing them at increased risk of pregnancy. This study will evaluate a new approach to beginning birth control pills. Women will take the first pill in the doctor's office rather than waiting until the next menstrual cycle.


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: EV/DNG (Qlaira, BAY86-5027, SH T00658K) | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: SH D 593 B (Miranova) | Intervention Type: DRUG; Name: EV/DNG (Qlaira, BAY86-5027, SH T00658K); Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: SH D 593 B (Miranova); Assigned to Arm(s): Arm 2
B: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: EV/DNG (Qlaira, BAY86-5027, SH T00658K) | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: SH D00264A (Triquilar) | Intervention Type: DRUG; Name: EV/DNG (Qlaira, BAY86-5027, SH T00658K); Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: SH D00264A (Triquilar); Assigned to Arm(s): Arm 2
C: Arm Label: NOMAC-E2; Type: EXPERIMENTAL; Interventions: Drug: NOMAC-E2 | Arm Label: DRSP-EE; Type: ACTIVE_COMPARATOR; Interventions: Drug: DRSP-EE | Intervention Type: DRUG; Name: NOMAC-E2; Assigned to Arm(s): NOMAC-E2 | Intervention Type: DRUG; Name: DRSP-EE; Assigned to Arm(s): DRSP-EE
D: Intervention Type: BEHAVIORAL; Name: Quick start oral contraceptive initiation; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pregnancy in Polycystic Ovary Syndrome: A 30 Week Double-Blind Randomized Trial of Clomiphene Citrate, Metformin XR, and Combined Clomiphene Citrate/Metformin XR For the Treatment of Infertility in Women With Polycystic Ovary Syndrome
Brief Summary: Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting up to 10% of women. The primary symptoms of PCOS are menstrual irregularities, increased body and facial hair, acne, and infertility. This study will test a combination of medications in women with PCOS to determine which works best to overcome infertility.


Options:
A: Arm Label: metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: metformin | Arm Label: liraglutide; Type: ACTIVE_COMPARATOR; Interventions: Drug: liraglutide | Arm Label: metformin and liraglutide; Type: ACTIVE_COMPARATOR; Interventions: Drug: metformin and liraglutide | Intervention Type: DRUG; Name: metformin; Assigned to Arm(s): metformin | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): liraglutide | Intervention Type: DRUG; Name: metformin and liraglutide; Assigned to Arm(s): metformin and liraglutide
B: Intervention Type: DRUG; Name: metformin XR; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: clomiphene citrate; Assigned to Arm(s): N/A
C: Arm Label: Metformin; Type: EXPERIMENTAL; Interventions: Drug: Metformin, Behavioral: Lifestyle Intervention | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Behavioral: Lifestyle Intervention | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Metformin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: BEHAVIORAL; Name: Lifestyle Intervention; Assigned to Arm(s): Metformin, Placebo
D: Arm Label: BMI > 32; Type: EXPERIMENTAL; Interventions: Drug: Metformin, Drug: Placebo | Arm Label: BMI </= 32; Type: EXPERIMENTAL; Interventions: Drug: Metformin + Clomiphene, Drug: Metformin, Drug: Clomiphene | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): BMI > 32 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): BMI > 32 | Intervention Type: DRUG; Name: Metformin + Clomiphene; Assigned to Arm(s): BMI </= 32 | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): BMI </= 32 | Intervention Type: DRUG; Name: Clomiphene; Assigned to Arm(s): BMI </= 32

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pregnancy in Polycystic Ovary Syndrome: A 30 Week Double-Blind Randomized Trial of Clomiphene Citrate, Metformin XR, and Combined Clomiphene Citrate/Metformin XR For the Treatment of Infertility in Women With Polycystic Ovary Syndrome
Brief Summary: Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting up to 10% of women. The primary symptoms of PCOS are menstrual irregularities, increased body and facial hair, acne, and infertility. This study will test a combination of medications in women with PCOS to determine which works best to overcome infertility.


Options:
A: Intervention Type: DRUG; Name: Simvastatin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Simvastatin and Metformin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: metformin XR; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: clomiphene citrate; Assigned to Arm(s): N/A
C: Arm Label: Metformin; Type: EXPERIMENTAL; Interventions: Drug: Metformin, Behavioral: Lifestyle Intervention | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Behavioral: Lifestyle Intervention | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Metformin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: BEHAVIORAL; Name: Lifestyle Intervention; Assigned to Arm(s): Metformin, Placebo
D: Intervention Type: DRUG; Name: simvastatin; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pregnancy in Polycystic Ovary Syndrome: A 30 Week Double-Blind Randomized Trial of Clomiphene Citrate, Metformin XR, and Combined Clomiphene Citrate/Metformin XR For the Treatment of Infertility in Women With Polycystic Ovary Syndrome
Brief Summary: Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting up to 10% of women. The primary symptoms of PCOS are menstrual irregularities, increased body and facial hair, acne, and infertility. This study will test a combination of medications in women with PCOS to determine which works best to overcome infertility.


Options:
A: Arm Label: Aromatase Inhibitors (AI); Type: ACTIVE_COMPARATOR; Interventions: Drug: Letrozole (aromatase inhibitor) | Arm Label: Clomiphene Citrate (CC); Type: ACTIVE_COMPARATOR; Interventions: Drug: Clomiphene Citrate | Arm Label: Follicle Stimulating Hormone (FSH); Type: ACTIVE_COMPARATOR; Interventions: Drug: Follicle Stimulating Hormone (gonadotropin) | Intervention Type: DRUG; Name: Letrozole (aromatase inhibitor); Assigned to Arm(s): Aromatase Inhibitors (AI) | Intervention Type: DRUG; Name: Clomiphene Citrate; Assigned to Arm(s): Clomiphene Citrate (CC) | Intervention Type: DRUG; Name: Follicle Stimulating Hormone (gonadotropin); Assigned to Arm(s): Follicle Stimulating Hormone (FSH)
B: Arm Label: M: Metformin P: Placebo; Type: EXPERIMENTAL; Interventions: Drug: Metformin / Placebo treatment for 4 months | Intervention Type: DRUG; Name: Metformin / Placebo treatment for 4 months; Assigned to Arm(s): M: Metformin P: Placebo
C: Intervention Type: DRUG; Name: metformin XR; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: clomiphene citrate; Assigned to Arm(s): N/A
D: Arm Label: BMI > 32; Type: EXPERIMENTAL; Interventions: Drug: Metformin, Drug: Placebo | Arm Label: BMI </= 32; Type: EXPERIMENTAL; Interventions: Drug: Metformin + Clomiphene, Drug: Metformin, Drug: Clomiphene | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): BMI > 32 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): BMI > 32 | Intervention Type: DRUG; Name: Metformin + Clomiphene; Assigned to Arm(s): BMI </= 32 | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): BMI </= 32 | Intervention Type: DRUG; Name: Clomiphene; Assigned to Arm(s): BMI </= 32

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Skills Training, Exposure, and Their Combination in Childhood Abuse PTSD
Brief Summary: This study will compare one- and two-component treatments in women with post-traumatic stress disorder (PTSD).


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: NET | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: NET; Assigned to Arm(s): A
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Prolonged Exposure | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Present Centered Therapy | Intervention Type: PROCEDURE; Name: Prolonged Exposure; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Present Centered Therapy; Assigned to Arm(s): 2
C: Arm Label: MBSR; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-based stress reduction | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mindfulness-based stress reduction; Assigned to Arm(s): MBSR
D: Arm Label: study arm; Type: EXPERIMENTAL; Interventions: Behavioral: Psychotherapy treatment | Intervention Type: BEHAVIORAL; Name: Psychotherapy treatment; Assigned to Arm(s): study arm

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of Treatment for Mild Gestational Diabetes Mellitus
Brief Summary: Gestational diabetes mellitus (GDM) is a type of diabetes (high blood sugar) that occurs in pregnant women. This study will determine whether treating pregnant women who have mild GDM improves the health of their babies. The follow-up study will examine whether factors during the previous pregnancy (such as blood sugar during pregnancy) are associated with the woman and her child's health 4-9 years later.


Options:
A: Arm Label: Glyburide (Glyburide vs Insulin); Type: N/A; Interventions: Drug: Glyburide vs Insulin trials | Arm Label: Insulin (Glyburide vs Insulin); Type: N/A; Interventions: Drug: Glyburide vs Insulin trials | Arm Label: Metformin (Metformin vs Insulin); Type: N/A; Interventions: Drug: Metformin vs Insulin trials | Arm Label: Insulin (Metformin vs Insulin); Type: N/A; Interventions: Drug: Metformin vs Insulin trials | Arm Label: Metformin (Metformin vs Glyburide); Type: N/A; Interventions: Drug: Metformin vs Glyburide trials | Arm Label: Glyburide (Metformin vs Glyburide); Type: N/A; Interventions: Drug: Metformin vs Glyburide trials | Intervention Type: DRUG; Name: Glyburide vs Insulin trials; Assigned to Arm(s): Glyburide (Glyburide vs Insulin), Insulin (Glyburide vs Insulin) | Intervention Type: DRUG; Name: Metformin vs Insulin trials; Assigned to Arm(s): Insulin (Metformin vs Insulin), Metformin (Metformin vs Insulin) | Intervention Type: DRUG; Name: Metformin vs Glyburide trials; Assigned to Arm(s): Glyburide (Metformin vs Glyburide), Metformin (Metformin vs Glyburide)
B: Arm Label: Nutritional counseling & self blood glucose monitoring; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: nutritional counseling, Behavioral: self blood glucose monitoring | Arm Label: No treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: nutritional counseling; Assigned to Arm(s): Nutritional counseling & self blood glucose monitoring | Intervention Type: BEHAVIORAL; Name: self blood glucose monitoring; Assigned to Arm(s): Nutritional counseling & self blood glucose monitoring
C: Arm Label: Low CHO; Type: EXPERIMENTAL; Interventions: Behavioral: Low CHO | Arm Label: High CHO; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: High CHO diet | Intervention Type: BEHAVIORAL; Name: Low CHO; Assigned to Arm(s): Low CHO | Intervention Type: DIETARY_SUPPLEMENT; Name: High CHO diet; Assigned to Arm(s): High CHO
D: Arm Label: exercise; Type: EXPERIMENTAL; Interventions: Behavioral: specific training program | Arm Label: control; Type: ACTIVE_COMPARATOR; Interventions: Other: standard | Intervention Type: OTHER; Name: standard; Assigned to Arm(s): control | Intervention Type: BEHAVIORAL; Name: specific training program; Assigned to Arm(s): exercise

Answer: B